Press Releases

Date	Title	Company
21-Jan-2026	Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine	Infinitopes
21-Jan-2026	Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI	ACCESS Newswire
21-Jan-2026	Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign	ACCESS Newswire
21-Jan-2026	Ensysce Biosciences Expands Global Opioid Patent Portfolio	ACCESS Newswire
21-Jan-2026	Cathpax, with its new Nova-X system, demonstrates its ability to offer interventional physicians an unmatched level of radiation protection to prevent all radiation-induced diseases and musculoskeletal disorders,thanks to a first-of-its-kind clinical study	Andrew Lloyd Associates
21-Jan-2026	Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company	ACCESS Newswire
21-Jan-2026	KKR-led Consortium Drives Further Investment in Sylvan	Businesswire
21-Jan-2026	Senzime Secures Major Ivy League US Hospital System Contract	ACCESS Newswire
21-Jan-2026	iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users	ACCESS Newswire
21-Jan-2026	BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)	ACCESS Newswire
21-Jan-2026	FluoGuide Submits an IND for FG001, to Initiate First U.S. Registration Trial	ACCESS Newswire
21-Jan-2026	SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions	ACCESS Newswire
21-Jan-2026	Oasis Submits Shareholder Proposals to Kobayashi Pharmaceutical for 2026 AGM	Businesswire
21-Jan-2026	enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.	Businesswire
21-Jan-2026	IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026	Businesswire
21-Jan-2026	Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners	ACCESS Newswire
21-Jan-2026	Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th	Businesswire
20-Jan-2026	Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com	Businesswire
20-Jan-2026	MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis	Businesswire
20-Jan-2026	Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in Combination with Keytruda®	Businesswire